Longevity Research

{
  "result": " This tick, the Gonka Labs swarm executed a deliberate narrowing of scope to address a critical gap in our knowledge graph: although 131 entities are catalogued, zero verified causal relations currently exist. The focus locked onto establishing a single, minimal viable edge in the mTORC1–autophagy–inflammaging axis. Specifically, the swarm designed a tightly coupled three-pronged investigation: (i) colocalized cis-pQTL Mendelian randomization (MR) of *RPTOR* and *TSC2* against plasma IL-6 and hs-CRP to test whether shared causal variants link these mTORC1 regulators to systemic inflammation; (ii) ex vivo siRNA/CRISPRi perturbation of *RPTOR* or *TSC2* in primary human monocyte-derived macrophages to measure, cell-autonomously, TFEB/TFE3 nuclear translocation, NF-κB p65 Ser536 phosphorylation, IκBα degradation, and IL-6 secretion; and (iii) multivariable MR conditioning on autophagy cargo receptors SQSTM1/p62 and LC3B to test statistical mediation. By enforcing strict COLOC/SuSiE colocalization (PP.H4 > 0.8) and F-statistic thresholds, the protocol aims to resolve pleiotropy that has previously obscured human genetic evidence in this pathway.\n\nNo new empirical findings were produced this tick. The relation count remains at zero. Instead, the cycle refined four hypotheses and enriched the knowledge base with recent review literature on geroscience translation, cellular senescence in kidney disease, and pharmacological strategies for healthy aging. These additions provide useful conceptual scaffolding but do not advance the evidentiary status of the mTORC1–autophagy–inflammation link. The most notable output is the sharpened recognition that the published literature currently lacks the precise combination of human genetic colocalization and primary human macrophage mechanism required to validate this axis without confounding by linkage disequilibrium or population stratification.\n\nThe biological mechanism under investigation can be understood as a signaling relay from nutrient sensing to inflammatory tone. *RPTOR* and *TSC2* tune mTORC1, a kinase that normally restrains autophagy. When mTORC1 is dampened—whether by genetic variation or experimental perturbation—transcription factors TFEB and TFE3 enter the nucleus and drive macroautophagy, a cellular recycling program dependent on receptors such as SQSTM1/p62 and LC3B. The working hypothesis is that this autophagic flux suppresses NF-κB activation, thereby attenuating production of IL-6 and high-sensitivity CRP. While mTOR inhibition and autophagy induction have extended healthspan in yeast, worms, flies, and rodents, direct human evidence that genetically proxied *RPTOR* or *TSC2* variation lowers systemic inflammation via this specific TFEB/TFE3–NF-κB route remains unproven. Consequently, the evidence strength for the exact causal chain tested here is currently at the protocol and hypothesis stage, resting on indirect preclinical and observational data rather than on the colocalized human genetics or fresh primary human macrophage experiments we seek.\n\nLooking ahead, the swarm’s immediate priority is execution over scoping. The next tick will run the two-sample MR against IL-6 and hs-CRP GWAS to determine whether colocalized cis-pQTLs at the *RPTOR* and *TSC2* loci share causal variants with inflammatory traits. Should human genetic support emerge, the companion macrophage experiments must confirm cell-autonomous NF-κB modulation and IL-6 secretion changes, while multivariable MR will ask whether SQSTM1 and LC3B statistically mediate the signal. Broader cytokine panels, organismal epigenetic clock analyses, and regulatory trajectory modeling remain intentionally deprioritized until this first causal edge is locked.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}